CVR number 40773223
Industry 26.6090 Manufacture of irradiation, electromedical and electrotherapeutic equipment

CHEXS ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.3% 2.3% 2.3% 2.3% 2.3%  
Bankruptcy risk  15.1% 5.4% 4.0% 2.2% 11.0%  
Credit score (0-100)  14 42 48 65 21  
Credit rating  BB BBB BBB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.1 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  -14.1 394 793 1,487 -43.4  
EBITDA  -14.1 30.1 225 851 -732  
EBIT  -14.1 30.1 225 851 -732  
Pre-tax profit (PTP)  -14.1 18.5 218.9 848.9 -740.9  
Net earnings  -14.1 15.7 170.7 678.3 -664.4  
Pre-tax profit without non-rec. items  -14.1 18.5 219 849 -741  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  25.9 41.5 212 890 226  
Interest-bearing liabilities  0.0 0.0 3.0 1.2 1.2  
Balance sheet total (assets)  25.9 801 467 1,516 418  
Net Debt  -20.3 -779 -285 -661 -374  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -14.1 394 793 1,487 -43.4  
Gross profit growth  0.0% 0.0% 101.1% 87.6% 0.0%  
Employees  0 1 2 1 3  
Employee growth %  0.0% 0.0% 100.0% -50.0% 200.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  26 801 467 1,516 418  
Balance sheet change%  0.0% 2,996.6% -41.7% 224.8% -72.4%  
Added value  -14.1 30.1 224.8 851.3 -732.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 7.6% 28.4% 57.3% 1,687.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -54.5% 7.3% 35.5% 85.9% -75.6%  
ROI %  -54.5% 89.5% 175.2% 143.9% -122.3%  
ROE %  -54.7% 46.5% 134.5% 123.0% -119.0%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  100.0% 26.1% 67.5% 68.2% 54.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  143.8% -2,584.5% -126.8% -77.6% 51.1%  
Gearing %  0.0% 0.0% 1.4% 0.1% 0.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 395.0% 122.1% 806.8%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  25,860.0 6.9 8.5 6.1 2.1  
Current Ratio  25,860.0 1.0 2.2 3.3 2.1  
Cash and cash equivalent  20.3 779.0 287.9 662.2 375.4  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  25.9 35.5 251.4 1,052.0 216.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 30 112 851 -244  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 30 112 851 -244  
EBIT / employee  0 30 112 851 -244  
Net earnings / employee  0 16 85 678 -221